Programs

  • Program 1 [2020]

    THE FUNDAMENTAL MISSION OF THE COGNITIVE RESEARCH ENTERPRISES, INC. ("CRE") IS TO DEVELOP A WORLD-CLASS BASIC SCIENCE AND CLINICAL RESEARCH PROGRAM FOR THE PURPOSE OF PREVENTING, DIAGNOSING, TREATING, AND CURING NEUROLOGICAL, PSYCHIATRIC, AND MEMORY DISORDERS AFFECTING THE BRAIN. CRE IS DEDICATED TO SEEKING PRACTICAL SOLUTIONS TO NEUROLOGICAL AND COGNITIVE IMPAIRMENT THROUGH FUNDAMENTAL RESEARCH, WITH SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE AND STATE-OF-THE-ART PRINCIPLES OF MOLECULAR AND CELLULAR NEUROBIOLOGY. THE BASE RESEARCH PROGRAM IN MEMORY AND MEMORY DISORDERS USES A MULTIDISCIPLINARY APPROACH THAT INTEGRATES AND (CONTINUED ON SCHEDULE O) APPLIES PRINCIPLES OF BEHAVIORAL RESEARCH, BRAIN IMAGING RESEARCH, BRAIN NETWORK SIGNALING RESEARCH, AND RESEARCH INTO THE SEQUENCE OF MOLECULAR STEPS INVOLVED IN MEMORY AND MEMORY DISORDERS. CRE'S RESEARCH CONSISTS OF BASIC AND CLINICAL SCIENCE IN RELATION TO: NEURODEGENERATIVE DISEASES AND OTHER COGNITIVE DISORDERS, PARTICULARLY THOSE INVOLVING LEARNING AND MEMORY; MOOD DISORDERS SUCH AS DEPRESSION, ANXIETY, AND SCHIZOPHRENIA CENTRAL NERVOUS SYSTEM INJURY, POST-TRAUMATIC STRESS DISORDER, AND OTHER AREAS OF FUNDAMENTAL NEUROSCIENCE AND NEURAL DISORDERS.
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $74.5K